Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine

Evolution of cervical cancer screening and prevention in United States and Canada: Implications for public health practitioners and clinicians

(2013) M. Saraiya et al.   PREVENTIVE MEDICINE

Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: A transmission-dynamic modeling study

(2013) Marc Brisson et al.   VACCINE

Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis

(2012) Nicolas Van de Velde et al.   JNCI-Journal of the National Cancer Institute

Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis

(2012) Talía Malagón et al.   LANCET INFECTIOUS DISEASES

Modeling Preventative Strategies against Human Papillomavirus-Related Disease in Developed Countries

(2012) Karen Canfell et al.   VACCINE

Human Papillomavirus Vaccine Introduction – The First Five Years

(2012) Lauri E. Markowitz et al.   VACCINE

Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine

(2009) Suzanne M. Garland et al.   JOURNAL OF INFECTIOUS DISEASES

Systematic review of human papillomavirus prevalence in invasive penile cancer

(2008) Danielle M. Backes et al.   CANCER CAUSES & CONTROL

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis

(2008) Hugo De Vuyst et al.   INTERNATIONAL JOURNAL OF CANCER